{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Sumio Ohtsuki"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Kumamoto University"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Sumio Ohtsuki"}]}], "description": "To identify a biomarker that can predict the response of preoperative chemoradiotherapy (PCRT). Twenty-five serum samples from patents with esophageal cancer before PCRT (responder = 13, non-responder = 12) were analyzed by quantitative proteomics. ", "fullDatasetLinks": [{"accession": "MS:1002633", "name": "jPOST dataset URI", "value": "https://repository.jpostdb.org/entry/JPST000554"}, {"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.biosciencedbc.jp/archive/jpostrepos/JPST000554"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD012819"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "3"}, {"accession": "MS:1002632", "name": "jPOST dataset identifier", "value": "JPST000554"}], "instruments": [{"accession": "MS:1000932", "name": "TripleTOF 5600"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "human, pre-PCRT, serum, esophageal cancer"}], "modifications": [{"accession": "MOD:01060", "name": "S-carboxamidomethyl-L-cysteine"}, {"accession": "MOD:00719", "name": "L-methionine sulfoxide"}, {"accession": "MOD:00046", "name": "O-phospho-L-serine"}, {"accession": "MOD:00047", "name": "O-phospho-L-threonine"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "31582665"}, {"accession": "MS:1002866", "name": "Reference", "value": "Nambu M, Masuda T, Ito S, Kato K, Kojima T, Daiko H, Ito Y, Honda K, Ohtsuki S Leucine-Rich Alpha-2-Glycoprotein 1 in Serum Is a Possible Biomarker to Predict Response to Preoperative Chemoradiotherapy for Esophageal Cancer. Biol Pharm Bull. 2019;42(10):1766-1771"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Proteome analysis of human serum from the esophageal cancer patient before preoperative chemoradiotherapy"}